SOLLI, VINCENZA
 Distribuzione geografica
Continente #
EU - Europa 376
NA - Nord America 320
AS - Asia 186
AF - Africa 21
Totale 903
Nazione #
US - Stati Uniti d'America 317
IT - Italia 210
VN - Vietnam 152
SE - Svezia 39
DE - Germania 32
GB - Regno Unito 27
CN - Cina 19
IE - Irlanda 17
BG - Bulgaria 11
IN - India 9
TG - Togo 9
CI - Costa d'Avorio 7
CH - Svizzera 6
AT - Austria 5
BE - Belgio 5
FI - Finlandia 5
NL - Olanda 5
RU - Federazione Russa 5
JO - Giordania 4
NG - Nigeria 4
CA - Canada 3
FR - Francia 3
EE - Estonia 2
PH - Filippine 2
RS - Serbia 2
ES - Italia 1
LU - Lussemburgo 1
ZA - Sudafrica 1
Totale 903
Città #
Bologna 57
Dong Ket 51
Chandler 50
Fabriano 27
Southend 25
Ashburn 24
Milan 20
Salsomaggiore Terme 20
Fairfield 18
Ann Arbor 17
Dublin 17
New York 12
Redmond 12
Sofia 11
Princeton 10
Lomé 9
Mondolfo 9
Wilmington 9
Abidjan 7
Seattle 7
Bern 6
Florence 6
Reggio Emilia 6
Turin 6
Amsterdam 5
Beijing 5
Berlin 5
Bremen 5
Brussels 5
Helsinki 5
Jinan 5
Riola 5
Vienna 5
Woodbridge 5
Abeokuta 4
Amman 4
Cambridge 4
Medford 4
San Lazzaro Di Savena 4
Augusta 3
Boydton 3
Des Moines 3
Houston 3
Irvine 3
Los Angeles 3
Redwood City 3
Stilo 3
Belgrade 2
Bo 2
Busseto 2
Falls Church 2
Frankfurt am Main 2
Nanchang 2
Nanjing 2
Naples 2
Parma 2
Pisa 2
Poggio Renatico 2
Rome 2
Saint Petersburg 2
San Francisco 2
Victoria 2
Westminster 2
Azzano Decimo 1
Boardman 1
Bockhorn 1
Brooklyn 1
Buffalo 1
Cagliari 1
Cernusco sul Naviglio 1
Glasgow 1
Hangzhou 1
Hebei 1
Henderson 1
Kilburn 1
Lamezia Terme 1
Madrid 1
Marseille 1
Matera 1
Modena 1
Mülheim 1
Olalla 1
Padova 1
Palombara Sabina 1
Phoenix 1
Pittsburgh 1
San Lazzaro di Savena 1
San Mateo 1
Shenyang 1
Stockholm 1
The Dalles 1
Toronto 1
Totale 591
Nome #
Adult "Triple Negative" ACUTE Lymphoblastic Leukemia Genome Wide Characterization 218
Chromothripsis in acute myeloid leukemia: Biological features and impact on survival 179
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma 99
null 98
VarianThinker: a classification method to confidently approach the mutation heterogeneity in Multiple Myeloma 71
A Methodologically Updated De-Novo Extraction of Copy Number Signatures in Multiple Myeloma: Clinical Significance and Putative Aetiologies 56
BoBafit: A copy number clustering tool designed to refit and recalibrate the baseline region of tumors’ profiles 55
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients 48
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases 40
Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents 33
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma 20
OAB-057: Temporal-weight estimation of the copy number alterations of of 1384 Multiple Myeloma patients defines an ancestrality index impacting patients survival 16
OAB-006: A novel algorithm to identify, characterize and define the prognostic impact of complex catastrophic events in Multiple Myeloma 8
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients 7
Rare, but complex chromosomal rearrangements, defined "Chromoanagenesis”, caused by single-step or stepwise catastrophic genomic events, significantly impact on Multiple Myeloma patients 5
Abstract 2700: Negative selective pressure exerted by maintenance therapy promotes the extinction of sub-clones carrying high-risk lesions in multiple myeloma 2
P-383 A 16-gene signature reflecting tumor microenvironment predicts the risk of multiple myeloma patients treated by bortezomib-based therapies 1
Totale 956
Categoria #
all - tutte 2.690
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.690


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20195 0 0 0 0 0 0 0 0 0 0 1 4
2019/202051 8 2 0 4 6 2 7 3 7 4 1 7
2020/2021147 5 2 0 2 2 1 4 9 8 1 3 110
2021/2022189 53 5 7 11 8 5 3 8 8 23 29 29
2022/2023333 18 32 18 25 46 21 9 15 38 13 46 52
2023/2024217 13 12 27 20 9 28 13 81 6 8 0 0
Totale 956